Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular anal...
Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
AimsDenosumab, a fully human monoclonal antibody directed against RANKL, has recently been introduced in the treatment strategy of giant cell tumour of bone (GCTB). Aim of this study was to investigate the phenotypical modifications induced by denosumab treatment in a series of 15 GCTB.MethodsThe tumours were characterised for histone 3.3 mutations...
Alternative Titles
Full title
Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1767079945
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1767079945
Other Identifiers
ISSN
0021-9746
E-ISSN
1472-4146
DOI
10.1136/jclinpath-2015-203248
